I‐Fen Chen
Impact in
-
- Curcumin's Biomedical Applications
-
- interferon and immune responses
- Immune Response and Inflammation
Papers in
-
- Natural product bioactivities and synthesis 2
- Oncology 4
- Cytokine Signaling Pathways and Interactions 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- Fu Ou‐Yang (3 shared papers)Ming‐Feng Hou (4 shared papers)Shyh‐Ming Kuo (5 shared papers)Shao‐Chun Wang (3 shared papers)Jen‐Yu Hung (1 shared paper)Gabriel N. Hortobágyi (1 shared paper)Mien‐Chie Hung (1 shared paper)Hongying Wang (1 shared paper)
- Journals
- Molecules (2 papers)Neoplasia (1 paper)Molecular Cancer Therapeutics (1 paper)Journal of Biomedical Materials Research Part B Applied Biomaterials (1 paper)Management Decision (1 paper)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
I‐Fen Chen
14 papers receiving 378 citations
Peers
Comparison fields: 5 of 83
- Molecular Medicine 31
- Immunology 80
- Oncology 83
- Biochemistry 19
- Molecular Biology 188
Countries citing papers authored by I‐Fen Chen
This map shows the geographic impact of I‐Fen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Fen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Fen Chen more than expected).
Fields of papers citing papers by I‐Fen Chen
This network shows the impact of papers produced by I‐Fen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Fen Chen. The network helps show where I‐Fen Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside I‐Fen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 118 | |
| 2 | 2006 | 50 | |
| 3 | 2015 | 46 | |
| 4 | 2013 | 34 | |
| 5 | 2010 | 31 | |
| 6 | 2018 | 27 | |
| 7 | 2014 | 16 | |
| 8 | 2018 | 16 | |
| 9 | 2010 | 12 | |
| 10 | 2016 | 11 | |
| 11 | 2017 | 10 | |
| 12 | 2023 | 6 | |
| 13 | Angelicin inhibits the growth and migration of triple-negative breast cancer cells. | 2023 | 3 |
| 14 | 2010 | 2 |
About I‐Fen Chen
I‐Fen Chen is a scholar working on Molecular Biology, Oncology, Biomaterials, Organic Chemistry and Rheumatology, having authored 14 papers that have together received 382 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers), Natural product bioactivities and synthesis (2 papers), Curcumin's Biomedical Applications (2 papers), Click Chemistry and Applications (1 paper), Silk-based biomaterials and applications (1 paper) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Molecular Medicine (31 citations), Immunology (80 citations), Oncology (83 citations), Biochemistry (19 citations) and Molecular Biology (188 citations). I‐Fen Chen has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Fu Ou‐Yang, Ming‐Feng Hou, Shyh‐Ming Kuo, Shao‐Chun Wang, Jen‐Yu Hung, Gabriel N. Hortobágyi, Mien‐Chie Hung, Hongying Wang, Shwu‐Jen Chang and Shyng‐Shiou F. Yuan. Their work appears in journals such as Molecules, Neoplasia, Molecular Cancer Therapeutics, Journal of Biomedical Materials Research Part B Applied Biomaterials and Management Decision.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.